BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23175466)

  • 1. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
    Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.
    Wang C; Yang W; Yan HX; Luo T; Zhang J; Tang L; Wu FQ; Zhang HL; Yu LX; Zheng LY; Li YQ; Dong W; He YQ; Liu Q; Zou SS; Lin Y; Hu L; Li Z; Wu MC; Wang HY
    Hepatology; 2012 Jan; 55(1):108-20. PubMed ID: 21932402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian disruption accelerates liver carcinogenesis in mice.
    Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F
    Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch2 signaling and undifferentiated liver cancers: evidence of hepatic stem/progenitor cell origin.
    Cardinale V; Carpino G; Reid LM; Gaudio E; Alvaro D
    Hepatology; 2013 Sep; 58(3):1188. PubMed ID: 23359130
    [No Abstract]   [Full Text] [Related]  

  • 8. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
    Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice.
    Tchorz JS; Kinter J; Müller M; Tornillo L; Heim MH; Bettler B
    Hepatology; 2009 Sep; 50(3):871-9. PubMed ID: 19551907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
    Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
    Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH2 signaling confers immature morphology and aggressiveness in human hepatocellular carcinoma cells.
    Hayashi Y; Osanai M; Lee GH
    Oncol Rep; 2015 Oct; 34(4):1650-8. PubMed ID: 26252838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STK33 promotes hepatocellular carcinoma through binding to c-Myc.
    Yang T; Song B; Zhang J; Yang GS; Zhang H; Yu WF; Wu MC; Lu JH; Shen F
    Gut; 2016 Jan; 65(1):124-33. PubMed ID: 25398772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
    Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
    J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.
    Geisler F; Nagl F; Mazur PK; Lee M; Zimber-Strobl U; Strobl LJ; Radtke F; Schmid RM; Siveke JT
    Hepatology; 2008 Aug; 48(2):607-16. PubMed ID: 18666240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
    Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
    Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.